Some studies have shown that PLXND1 was overexpressed in tumor cells and promoted tumor development and progression in several cancers, including colon cancers (11), melanoma (30), pancreatic cancer (31), and ovarian cancer (12). This evidence concerns the gene PLXND1 and ovarian cancer.